Utah's Newborn Screening Program finds 45 genetic disorders shortly after a baby is born. New conditions are added to the list as screening tests and treatments become available. Hunter syndrome, a ...

It's long been assumed the Jomon people, who had inhabited the Japanese archipelago since around 16,000 years ago, had multiple lineages resulting from different migration routes. But new genetic ...

In Grow a Garden, players can improve a fruit’s appearance and value through different mutations. Some mutations are obtained from pets, weather, and admin events, while others come from special gear.

Researchers have discovered new regions of the human genome particularly vulnerable to mutations. These altered stretches of DNA can be passed down to future generations and are important for how we ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

GameSpot may get a commission from retail offers. The outdoors feels more dangerous than ever in Grounded 2, and many bug types seem eager to bully you. Completing challenges will help you earn ...

A newly discovered genetic mutation unique to humans may help explain why we are significantly more vulnerable to cancer than our closest evolutionary relatives. Researchers at the University of ...

Add Yahoo as a preferred source to see more of our stories on Google. A new "proteomic" blood test can accurately screen a newborn's DNA for thousands of rare, inherited diseases by analyzing just a ...

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...

Panelists discuss how to approach second-line therapy decisions for patients with metastatic breast cancer, emphasizing the importance of biomarker testing, including ESR1 mutations, and considering ...